Article
Thymidylate synthase disruption to limit cell proliferation in cell therapies
2023-06-26
Abstract excerpt
Engineered cells hold great promise for regenerative medicine and gene therapy. However, living cell products entail a fundamental biological risk of unwanted growth. Here, we describe a novel metabolic safety system to control cell proliferation without added genetic elements. We inactivated a key enzyme for nucleotide metabolism, TYMS , in several cell lines, thus obtaining cells that proliferate only when supp...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 28f1b30d-4a61-5425-a162-25b53c8aea1a
- DOI
- 10.1101/2023.06.26.546441
